Show
10
20
30
40
results per page
COVID-19 Variant Supplement – Development of a novel DC-targeting vaccine that targets COVID‑19 spike protein to control COVID‑19 infection
Yao, Xiao-Jian |
University of Manitoba | Operating Grant | $50,000
CIHR Manitoba 2021
Read More
Enhancing culturally-safe ways for community wholistic health and wellness aspirations during COVID-19.
Warburton, Darren E |
University of British Columbia | Other | $99,324
CIHR British Columbia 2021
Read More
COVID-19 Variant Supplement – Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.
Moitessier, Nicolas R |
McGill University | Operating Grant | $50,000
CIHR Quebec 2021
Read More
Unpacking COVID‑19 Vaccine Hesitancy in Canada
Dubé, Eve |
Université Laval | Operating Grant | $499,870
CIHR Quebec 2021
Read More
Prevention of the immunopathology induced by SARS-CoV-2
Estaquier, Jérôme |
Université Laval | Operating Grant | $499,800
CIHR Quebec 2021
Read More
Parental presence restrictions due to COVID-19: Examining impact and priorities for neonatal care (The PRESENCE Study)
Campbell-Yeo, Marsha L |
Dalhousie University | Operating Grant | $193,100
CIHR Nova Scotia 2021
Read More
Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID‑19 outcomes.
Su, Ruey-Chyi |
University of Manitoba | Operating Grant | $431,000
CIHR Manitoba 2021
Read More
Targeting the novel coronavirus SARS-CoV-2 using an ancient antibody system
Ehrhardt, Rudolf A |
University of Toronto | Project Grant | $229,500
CIHR Ontario 2021
Read More
COVID19 persistent symptomatology: an investigation of the metabolomic and proteomic underpinning
Corbeil, Jacques |
Université Laval | Operating Grant | $394,000
CIHR Quebec 2021
Read More
A rapid assessment of the impact of the COVID‑19 pandemic on supervised consumption services in Canada
Hyshka, Elaine |
University of Alberta | Operating Grant | $213,762
CIHR Alberta 2021
Read More